PLGA-PEG-NH2
PLGA-PEG-NH2 is a material to synthesis nanomicelles. PLGA-PEG-NH2 nanomicelle is an efficient delivery system of Irinotecan for targeted colorectal cancer and hepatocellular carcinoma[1].
Product Specifications
UNSPSC
12352211
Target
Biochemical Assay Reagents
Type
Oligonucleotides
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/plga-peg-nh2.html
Purity
98.0
Solubility
DMSO : 100 mg/mL (ultrasonic) |Ethanol : < 1 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
OC(C)C(OCC(NCCOCCN)=O)=O.[x].[y].[n]
References & Citations
[1]Emami J, et al. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan. Pharm Dev Technol. 2018;23 (1) :41-54.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC403644-100 1x 100 µL
CD3e (T-Cell Marker) (rC3e/1931), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
